NF Trinity Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $11.2M | Buy |
82,500
+20,000
| +32% | +$2.7M | 1.78% | 15 |
|
|
2018
Q4 | $6.09M | Hold |
62,500
| – | – | 0.99% | 27 |
|
|
2018
Q3 | $8.69M | Buy |
62,500
+16,500
| +36% | +$2.29M | 1.15% | 23 |
|
|
2018
Q2 | $5.71M | Hold |
46,000
| – | – | 0.78% | 32 |
|
|
2018
Q1 | $5.13M | Hold |
46,000
| – | – | 0.71% | 34 |
|
|
2017
Q4 | $5.5M | Hold |
46,000
| – | – | 0.72% | 31 |
|
|
2017
Q3 | $6.45M | Hold |
46,000
| – | – | 0.92% | 29 |
|
|
2017
Q2 | $5.6M | Hold |
46,000
| – | – | 0.79% | 29 |
|
|
2017
Q1 | $5.58M | Hold |
46,000
| – | – | 0.75% | 28 |
|
|
2016
Q4 | $5.63M | Hold |
46,000
| – | – | 0.79% | 29 |
|
|
2016
Q3 | $5.64M | Buy |
+46,000
| New | +$5.64M | 0.63% | 32 |
|